STEPHANNIE SIWIK-SIMPSON: Open Payments
NPI 1578272597 · GREENWICH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 23 payments from 9 companies in 2025. Trend: 2023 $854 · 2024 $210 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $248 |
| Novo Nordisk Inc | 4 | $163 |
| GlaxoSmithKline, LLC. | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| PFIZER INC. | 2 | $41 |
| Exact Sciences Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: AIRSUPRA, Ozempic, FARXIGA, REXULTI, AREXVY, Wegovy, ELIQUIS, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
